Cysteine-Rich Protective Antigen (CyRPA) as promising blood-stage candidate protein for inclusion in a malaria subunit vaccine

समान संसाधन

• Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA)
  द्वारा: Anjali Somanathan, और अन्य
  प्रकाशित: (2022-09-01)
• Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against Plasmodium falciparum CyRPA
  द्वारा: Anne S. Knudsen, और अन्य
  प्रकाशित: (2021-08-01)
• The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations
  द्वारा: Leonard Ndwiga, और अन्य
  प्रकाशित: (2021-06-01)
• Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization
  द्वारा: Vinayaka Kotraiah, और अन्य
  प्रकाशित: (2021-07-01)
• Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate
  द्वारा: Bárbara Fernandes, और अन्य
  प्रकाशित: (2022-05-01)